Boston Translational LLC
Amendment
CIK: 0001717227·Biotechnology·DELAWARE·Filed: Apr 16, 2018
Total Offering
$4,000,000
Amount Sold
$1,825,000
Investors
4
First Sale
Sep 7, 2017
Offering Details
- Type
- Equity, Debt, Other: Per the operating agreement, investors receive return of their invested capital plus a preferred return percentage (before distributions are made according to % ownership) in addition to an equity state in the LLC.
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Year Incorporated
- 2017
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Paul Holzer | Related Person |
| Krysta Moulton | Related Person |
Company
SEC Filing
0001717227-18-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free